TEVA vs. SATS
TEVA (Teva Pharmaceutical Industries Limited) and SATS (EchoStar Corporation) are both stocks. TEVA operates in Drug Manufacturers - Specialty & Generic (Healthcare), while SATS operates in Communication Equipment (Technology). Over the past 10 years, TEVA returned -4.15%/yr vs 82.90%/yr for SATS. At a 0.26 correlation, their price movements are largely independent.
Performance
TEVA vs. SATS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TEVA achieves a 6.57% return, which is significantly lower than SATS's 7.29% return. Over the past 10 years, TEVA has underperformed SATS with an annualized return of -4.15%, while SATS has yielded a comparatively higher 82.90% annualized return.
TEVA
- 1D
- -2.72%
- 1M
- -6.91%
- YTD
- 6.57%
- 6M
- 17.40%
- 1Y
- 87.17%
- 3Y*
- 65.55%
- 5Y*
- 25.39%
- 10Y*
- -4.15%
SATS
- 1D
- 0.29%
- 1M
- -8.28%
- YTD
- 7.29%
- 6M
- 32.13%
- 1Y
- 567.16%
- 3Y*
- 89.93%
- 5Y*
- 34.20%
- 10Y*
- 82.90%
TEVA vs. SATS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TEVA Teva Pharmaceutical Industries Limited | 6.57% | 41.61% | 111.11% | 14.47% | 13.86% | -16.99% | -1.53% | -36.45% | -18.63% | -46.18% |
SATS EchoStar Corporation | 7.29% | 374.67% | 38.20% | -0.66% | -36.70% | 24.35% | -51.07% | 16,499.32% | -38.70% | 16.56% |
Correlation
The correlation between TEVA and SATS is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Jan 3, 2008 | 0.26 |
Fundamentals
TEVA:
$39.21B
SATS:
$33.70B
TEVA:
$1.34
SATS:
-$80.77
TEVA:
2.24
SATS:
2.27
TEVA:
4.76
SATS:
5.99
TEVA:
$17.35B
SATS:
$14.80B
TEVA:
$9.03B
SATS:
$5.79B
TEVA:
$3.05B
SATS:
-$16.89B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TEVA vs. SATS — Risk / Return Rank
TEVA
SATS
TEVA vs. SATS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and EchoStar Corporation (SATS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TEVA | SATS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.18 | ||
| Sortino ratioReturn per unit of downside risk | -2.90 | ||
| Omega ratioGain probability vs. loss probability | 1.43 | 1.83 | -0.39 |
| Calmar ratioReturn relative to maximum drawdown | 4.02 | 28.74 | -24.72 |
| Martin ratioReturn relative to average drawdown | 10.94 | 53.08 | -42.14 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| TEVA | SATS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.25 | 5.43 | -3.18 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.59 | 0.50 | +0.10 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.09 | 0.02 | -0.11 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.31 | 0.01 | +0.30 |
Drawdowns
TEVA vs. SATS - Drawdown Comparison
The maximum TEVA drawdown since its inception was -90.89%, which is greater than SATS's maximum drawdown of -78.33%. Use the drawdown chart below to compare losses from any high point for TEVA and SATS.
Loading charts...
Drawdown Indicators
| TEVA | SATS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.89% | -78.33% | -12.56% |
Max Drawdown (1Y)Largest decline over 1 year | -21.79% | -19.91% | -1.88% |
Max Drawdown (3Y)Largest decline over 3 years | -43.70% | -59.22% | +15.52% |
Max Drawdown (5Y)Largest decline over 5 years | -43.70% | -68.02% | +24.32% |
Max Drawdown (10Y)Largest decline over 10 years | -88.41% | -78.33% | -10.08% |
Current DrawdownCurrent decline from peak | -50.84% | -17.76% | -33.08% |
Average DrawdownAverage peak-to-trough decline | -32.00% | -31.23% | -0.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.00% | 10.78% | -2.78% |
Volatility
TEVA vs. SATS - Volatility Comparison
The current volatility for Teva Pharmaceutical Industries Limited (TEVA) is 9.18%, while EchoStar Corporation (SATS) has a volatility of 16.97%. This indicates that TEVA experiences smaller price fluctuations and is considered to be less risky than SATS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TEVA | SATS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.18% | 16.97% | -7.79% |
Volatility (6M)Calculated over the trailing 6-month period | 23.54% | 42.26% | -18.72% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.97% | 105.56% | -66.59% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.94% | 69.15% | -26.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 47.34% | 4,552.27% | -4,504.93% |
Dividends
TEVA vs. SATS - Dividend Comparison
Neither TEVA nor SATS has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SATS EchoStar Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 85.50% | 0.00% | 0.00% | 0.00% | 0.00% |
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.88% | 3.19% | 1.77% |
Financials
TEVA vs. SATS - Financials Comparison
This section allows you to compare key financial metrics between Teva Pharmaceutical Industries Limited and EchoStar Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TEVA vs. SATS - Profitability Comparison
TEVA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a gross profit of 1.97B and revenue of 3.98B. Therefore, the gross margin over that period was 49.5%.
SATS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, EchoStar Corporation reported a gross profit of 1.67B and revenue of 3.67B. Therefore, the gross margin over that period was 45.5%.
TEVA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported an operating income of 652.00M and revenue of 3.98B, resulting in an operating margin of 16.4%.
SATS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, EchoStar Corporation reported an operating income of 392.85M and revenue of 3.67B, resulting in an operating margin of 10.7%.
TEVA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a net income of 369.00M and revenue of 3.98B, resulting in a net margin of 9.3%.
SATS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, EchoStar Corporation reported a net income of -189.14M and revenue of 3.67B, resulting in a net margin of -5.2%.
Frequently Asked Questions
TEVA and SATS have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SATS has higher volatility (16.97%) compared to TEVA (9.18%). In terms of maximum drawdown, TEVA dropped -90.89% vs SATS's -78.33%.
SATS currently has the higher Sharpe Ratio (5.43 vs 2.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TEVA and SATS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer